Department of Radiology, The First Hospital of China Medical University; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors (China Medical University), Ministry of Education, Shenyang, China.
Department of Surgical Oncology and General Surgery, The First Hospital of China Medical University; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors (China Medical University), Ministry of Education, Shenyang, China.
BJS Open. 2023 Jul 10;7(4). doi: 10.1093/bjsopen/zrad075.
Previous meta-analyses reporting significant associations between perioperative allogeneic blood transfusions and poor prognosis in gastric cancer or colorectal cancer had a high risk of confounding bias. This meta-analysis explored this issue using observational studies that applied propensity score analysis.
PubMed, Embase, and the Cochrane Central Register of Controlled Trials were searched for manuscripts published between 2013 and 2022. Studies applying propensity score analysis were included to investigate the association between perioperative allogeneic blood transfusions and prognosis in gastric cancer or colorectal cancer after radical surgery. Pooled HRs for overall survival and disease-free survival were calculated using a fixed-effect model or random-effect model according to heterogeneity.
Twelve retrospective cohort studies with 17 607 patients reported were included. Ten studies applied propensity score matching and two applied inverse probability of treatment weighting using propensity score. A total of 5962 patients were analysed after propensity score adjustment. After propensity score adjustment, perioperative allogeneic blood transfusions did not correlate with disease-free survival in gastric cancer (HR 1.16; 95 per cent c.i. 0.96-1.39; heterogeneity was assessed by the chi-squared test and inconsistency index (I2) = 57 per cent) or colorectal cancer (HR 1.12; 95 per cent c.i. 0.84-1.49; I2 = 54 per cent). However, after propensity score adjustment, perioperative allogeneic blood transfusions were significantly associated with worse overall survival in gastric cancer (HR 1.20; 95 per cent c.i. 1.08-1.32; I2 = 25 per cent) and colorectal cancer (HR 1.40; 95 per cent c.i. 1.06-1.85; I2 = 52 per cent). Subgroup analyses showed that perioperative allogeneic blood transfusions did not correlate with overall survival in colorectal cancer when major postoperative complications were balanced after propensity score.
Perioperative allogeneic blood transfusion is not correlated with recurrence of gastric cancer and colorectal cancer. Perioperative allogeneic blood transfusions are significantly associated with worse overall survival in gastric cancer and colorectal cancer, which may be attributable to unbalanced major postoperative complications after propensity score adjustment.
先前报告围手术期异体输血与胃癌或结直肠癌不良预后之间存在显著关联的荟萃分析存在混杂偏倚的高风险。本荟萃分析使用应用倾向评分分析的观察性研究探讨了这一问题。
检索了 2013 年至 2022 年期间发表的文献,使用 PubMed、Embase 和 Cochrane 对照试验中心注册库。纳入应用倾向评分分析的研究,以调查根治性手术后围手术期异体输血与胃癌或结直肠癌预后之间的关系。使用固定效应模型或随机效应模型根据异质性计算总生存和无病生存的合并 HR。
共纳入 12 项回顾性队列研究,共 17607 例患者。10 项研究采用倾向评分匹配,2 项研究采用倾向评分逆概率处理权重。共分析了 5962 例患者进行倾向评分调整后。在倾向评分调整后,围手术期异体输血与胃癌(HR 1.16;95%置信区间 0.96-1.39;通过卡方检验和不一致指数(I2)评估异质性=57%)或结直肠癌(HR 1.12;95%置信区间 0.84-1.49;I2=54%)的无病生存无关。然而,在倾向评分调整后,围手术期异体输血与胃癌的总生存显著相关(HR 1.20;95%置信区间 1.08-1.32;I2=25%)和结直肠癌(HR 1.40;95%置信区间 1.06-1.85;I2=52%)。亚组分析显示,在倾向评分后平衡主要术后并发症后,围手术期异体输血与结直肠癌的总生存无关。
围手术期异体输血与胃癌和结直肠癌的复发无关。围手术期异体输血与胃癌和结直肠癌的总生存显著相关,这可能归因于倾向评分调整后主要术后并发症的不平衡。